Treatment Overview

The AML treatment that a patient receives depends on a number of factors, for example, age, other medical conditions and the specific type of AML that the person is suffering from.

Patients who are “fit” (no prior significant medical conditions) and under 70 years old are usually given intravenous (IV) chemotherapy, which requires hospitalisation for 3–4 weeks. Older and more “frail” (patients with serious prior medical conditions) patients may be given different treatment options, such as subcutaneous (applied under the skin) or oral (taken by the mouth) therapies.

Watch the videos in this section to learn more about various treatment options available for AML and to gain a better understanding of how to best approach your doctors with treatment questions.



AML Expert Dr. Garcia-Manero Discusses New AML Research

Dr. Guillermo Garcia-Manero provides an overview of recent advances in AML care and insight to where treatment research is headed. Watch now to learn more.


Finding a Match for AML Therapy: How Are Genetic Test Results Used?

Can AML therapy be tailored to a person’s genetic profile? Watch as Dr. Uma Borate discusses mutations doctors test for and how treatment strategy changes.


Genetic Subtypes for AML: How Does Mutational Status Influence Care?

How do genetic test results affect AML treatment decisions, and when is the best time for testing? Watch now to find out from leading expert Dr. Uma Borate.


Ask the AML Expert: What Do New Drugs Mean for My AML?

‘We’ve had years and years of research that we’ve been building upon to get to this point,’ says noted AML expert Dr. Daniel Pollyea. Watch this Ask the Expert replay to learn about advances for patients.


How Is the AML Treatment Landscape Evolving?

What’s happening in AML treatment research? Watch now to hear expert Dr. Thomas LeBlanc give an encouraging update on new approaches to AML treatment, genetic profiling and more.


Will CAR T-Cell Therapy Work for Solid Tumor Cancers?

Is CAR T-cell therapy on the horizon for patients with solid tumor cancers? Watch as Dr. David Maloney discusses advances in CAR-T research, current clinical studies, treatment efficacy and more.


What Is the Relationship Between Emotional Stress and AML Prognosis?

Is there a connection between emotional distress and AML prognosis? Listen as Dr. Thomas LeBlanc shares findings from a recent clinical study on factors that influence treatment outcomes and patient response rates.


What Are the Current Treatment Options for AML?

During this “What Are the Current Treatment Options for AML?” full-length replay, a panel of AML experts and patients share exciting developments in treatment research and the impact on patients. Watch now to learn more.


How Can AML Patients Get Involved With Clinical Trials?

Even though U.S. clinical trial enrollment is very low, the trials bring development and new medicines to patients. Watch as Leah Szumita breaks down how patients can get involved.


Showing 9 of 62 programs
Join Our Community Register for Events Read Our Latest Blog

Page last updated on June 30, 2019